Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis

被引:3
作者
Wu, Zhiyong [1 ,2 ]
Zhu, Yu [1 ,2 ]
Zhang, Min [1 ,2 ]
Wang, Chen [1 ,2 ]
Zhou, Lingli [1 ,2 ]
Liu, Wei [1 ,2 ]
Yang, Wenjia [1 ,2 ]
Li, Meng [1 ,2 ]
Zhang, Simin [1 ,2 ]
Ren, Qian [1 ,2 ]
Han, Xueyao [1 ,2 ]
Ji, Linong [1 ,2 ]
机构
[1] Peking Univ, Diabet Ctr, Peoples Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] Peking Univ, Diabet Ctr, Peoples Hosp, Dept Metab, Beijing, Peoples R China
关键词
Graves' disease; autoimmune thyroiditis; thyrotoxicosis; thyroid function test; differential diagnosis; DIFFERENTIAL-DIAGNOSIS; RECEPTOR ANTIBODIES; CLINICAL-FEATURES; AUTOMATED-ASSAY; HYPERTHYROIDISM; THYROTOXICOSIS; TSH; DESTRUCTION; IMMUNOASSAY; THYROXINE;
D O I
10.3389/fendo.2020.620407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Graves' disease (GD) and autoimmune thyroiditis (AIT) are two major causes of thyrotoxicosis that require correct diagnosis to plan appropriate treatment. The objectives of this study were to evaluate the usefulness of thyroid-related parameters for distinguishing GD from AIT and identify a novel index for differential diagnosis of thyrotoxicosis. Design: This retrospective study was performed using electronic medical records in Peking University People's Hospital (Beijing, China). Methods: In total, 650 patients with GD and 155 patients with AIT from December 2015 to October 2019 were included in cohort 1. Furthermore, 133 patients with GD and 14 patients with AIT from December 2019 to August 2020 were included in cohort 2 for validation of the novel index identified in cohort 1. All patients were of Chinese ethnicity and were newly diagnosed with either GD or AIT. Thyroid-related clinical information was collected before intervention by reviewing the patients' electronic medical records. Receiver operating characteristic curve analysis was used to identify the optimal cutoff for distinguishing GD from AIT. Results: In cohort 1, thyroid-stimulating hormone (TSH) receptor antibody was identified as the best indicator for distinguishing GD from AIT. The area under the receiver operating characteristic curve was 0.99(95% confidence interval: 0.98-0.99, p<0.0001)and the optimal cutoff was 0.84 IU/l (98% sensitivity and 99% specificity). The free triiodothyronine (FT3)/TSH ratio (FT3/TSH) was the second -best for distinguishing GD from AIT, the area under the receiver operating characteristic curve of FT3/TSH was 0.86 (95% confidence interval: 0.84-0.88, p<0.0001); its optimal cutoff was 1.99 pmol/mIU (79% sensitivity and 80% specificity). Its effectiveness was confirmed in cohort 2 (81% sensitivity and 100% specificity). Conclusions: The FT3/TSH ratio is a new useful index for differential diagnosis of thyrotoxicosis, especially when combined with TRAb.
引用
收藏
页数:7
相关论文
共 43 条
[31]   Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach [J].
Naghashpour, Mahshid ;
Darvishi, Ali ;
Adelipour, Maryam ;
Bagheri, Reza ;
Wong, Alexei ;
Suzuki, Katsuhiko ;
Golabi, Sahar .
MEDICINA-LITHUANIA, 2022, 58 (07)
[32]   Serum Thyroid-Stimulating Hormone Concentration and Morbidity from Cardiovascular Disease and Fractures in Patients on Long-Term Thyroxine Therapy [J].
Flynn, Robert W. ;
Bonellie, Sandra R. ;
Jung, Roland T. ;
MacDonald, Thomas M. ;
Morris, Andrew D. ;
Leese, Graham P. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) :186-193
[33]   Thyroid-stimulating hormone receptor antibodies during follow-up as remission markers in childhood-onset Graves' disease treated with antithyroid drugs [J].
Wang, Shuo-Yu ;
Wang, Chia-Ti ;
Tien, Kai-Jen ;
Chang, Chao-Chun ;
Liu, Ting-Hsiu .
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2020, 36 (04) :281-286
[34]   Comparison of Enzyme-Linked Immunosorbent Assay and Lateral Flow Assay to Measure Thyroid-Stimulating Hormone and Free T4 in Human Serum [J].
Advincula-Espino, Rolando ;
Li, Jair ;
Rosales-Rimache, Jaime .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2025, 39 (10)
[35]   Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves' disease patients with hyperthyroidism or subjects with euthyroidism: A prospective observational study [J].
Tseng, Fen-Yu ;
Chen, Yen-Ting ;
Chi, Yu-Chiao ;
Chen, Pei-Lung ;
Yang, Wei-Shiung .
MEDICINE, 2019, 98 (11)
[36]   Correlation of circulating miRNA-146a-5p and let-7b expression with thyroid-stimulating hormone receptor antibody in patients with graves disease [J].
Al-Heety, Rashad Ayad ;
Al-Hadithi, Hayfaa S. ;
Turki, Kismat M. .
GENE REPORTS, 2020, 19
[37]   Changes in Th9 and Th17 lymphocytes and functional cytokines and their relationship with thyroid-stimulating hormone receptor antibodies at different stages of graves' disease [J].
Ren, Xuan ;
Chen, Hui .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[38]   Can Digit Ratio (2D:4D) Be Indicative of Predispositions to Autoimmune Thyroid Diseases in Women-Hashimoto Thyroiditis and Graves' Disease? [J].
Swiechowicz, Barbara ;
Kasielska-Trojan, Anna ;
Manning, John T. ;
Antoszewski, Boguslaw .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[39]   Free Thyroxine, Anti-Thyroid Stimulating Hormone Receptor Antibody Titers, and Absence of Goiter Were Associated with Responsiveness to Methimazole in Patients with New Onset Graves' Disease [J].
Choi, Hoon Sung ;
Yoo, Won Sang .
ENDOCRINOLOGY AND METABOLISM, 2017, 32 (02) :281-287
[40]   Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria [J].
Porto Silva Janovsky, Carolina Castro ;
Cesena, Fernando H. ;
Tabone Valente, Viviane Arevalo ;
de Oliveira Conceicao, Raquel Dilguerian ;
Santos, Raul D. ;
Bittencourt, Marcio Sommer .
EUROPEAN THYROID JOURNAL, 2018, 7 (06) :302-307